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Abstract 22 
A worrisome phenomenon is the progressive global spread of Enterobacteriaceae harbouring 23 
plasmid-mediated production of enzymes which inactivate β-lactam-antibiotics into the 24 
environment and subsequent colonization of synanthropic and wild animal populations. The 25 
aim of this study was to investigate the presence of higher generation cephalosporin resistant 26 
Escherichia coli in faecal samples of feral pigeons (Columba livia) located in the city of 27 
Zurich and of great cormorants (Phalacrocorax carbo) located on the banks of the Rhine and 28 
to further characterize detected isolates.  Six strains were isolated from 298 pigeons and 30 29 
cormorants. Three (1%) of the pigeons and 2 (6.7%) of the cormorants were found to carry 30 
multidrug- resistant, predominantly pathogenicity-associated extra-intestinal E.coli. The 31 
worlwide frequently found blaCTX-M-15 was detected in one pigeon and one cormorant isolate. 32 
Three pigeon strains harboured  the plasmid-encoded AmpC-β-lactamase gene blaCMY-2. One 33 
cormorant was found to carry the pandemic E.coli ST 131 clone containing blaCTX-M-27. Both 34 
urban pigeons and great cormorants in Switzerland are potential carriers of epidemiologically 35 
important  ESBL-producing E. coli. Transmission of multiresistant strains into the urban 36 
environment and waterways via their faecal deposits constitute a potential hazard to public 37 
health. 38 
 39 
Keywords: 40 
ESBL; Escherichia coli; birds; faecal carriage; wildlife; reservoir 41 
 42 
 43 
 44 
 45 
 46 
 47 
  3 
 48 
1. Introduction 49 
One of the currently most important antibiotic resistance mechanisms in 50 
Enterobacteriaceae is based on plasmid-mediated production of enzymes which inactivate β-51 
lactam-antibiotics including cephalosporins and monobactams by hydrolyzing their β-lactam 52 
ring. These so-called extended-spectrum β-lactamases (ESBLs) have been detected in human 53 
clinical isolates of Enterobacteriaceae since the early 1990s  (Paterson and Bonomo, 2005) 54 
originally as derivates of the TEM- and SHV-β-lactamase families, then increasingly as CTX-55 
M enzymes, or other less frequent ESBLs such as OXA- or PER-ESBLs  (Bush and Jacoby, 56 
2010; Coque et al., 2008). In addition, plasmid-mediated AmpC-type ß-lactamases (pAmpCs) 57 
are increasingly reported world-wide, representing a new threat to successful antibiotic 58 
therapy because they are not, like ESBLs, susceptible to ß-lactamase inhibitors such as 59 
clavulanic acid or sulbactam, and they possess a wider spectrum of enzymatic activity  60 
(Philippon et al., 2002).  61 
As a further matter of concern, resistance caused by ESBLs or pAmpCs is often 62 
associated with resistance to other classes of antibiotics such as fluoroquinolones, 63 
aminoglycosides, and sulfamethoxazole/trimethoprim, resulting in multidrug resistant strains  64 
(Coque et al., 2008). 65 
Since the first description of ESBL-producing Enterobacteriaceae from hospitalized 66 
humans, ESBL-producing Escherichia coli have been reported in numerous nosocomial and 67 
later also community-associated infections worldwide (Paterson and Bonomo, 2005) and have 68 
been detected in food-producing animals (Carattoli, 2008) and household pets (Ewers et al., 69 
2011). In addition, ESBL-producing E. coli appear to be spreading into the natural 70 
environment, resulting in wildlife populations that act as reservoirs and disseminators of 71 
ESBL-producing Enterobacteriaceae (Guenther et al., 2011). Several studies have described 72 
antibiotic resistant Enterobacteriaceae in gulls (Bonnedahl et al., 2010; Poirel et al., 2012), 73 
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water birds  (Tausova et al., 2012) and pigeons  (Radimersky et al., 2010), suggesting that 74 
birds play an important role in the epidemiology of resistance genes. 75 
The aim of the present study was therefore (i) to assess the prevalence of resistance to 76 
extended-spectrum ß-lactam antibiotics in Enterobacteriaceae harboured by a population of 77 
urban pigeons (Columba livia forma domestica) in the city of Zurich, Switzerland as well as 78 
by great cormorants (Phalacrocorax carbo) from in the banks of the Rhine river in the 79 
northern district of the Canton of Zurich, Switzerland and (ii) to characterize such isolates by 80 
antibiotic susceptibility testing, identification of the blaESBL/blapAmpC genes, multi-locus 81 
sequence typing (MLST), determination of phylogenetic groups and detection of virulence 82 
genes. 83 
 84 
2. Material and methods 85 
 86 
2.1 Bacterial isolates 87 
Pigeon swabs were obtained from the pigeon management programme in the city of 88 
Zurich. Between March 2012 and August 2012, a total of 298 postmortem cloacal swabs were 89 
taken from culled pigeons by an authorized gamekeeper using a swab tube containing Amies 90 
gel transport medium (Copan, Brescia, Italy). Tubes were numbered consecutively and sent to 91 
the laboratory for analysis. 92 
Cormorants were shot between December 2011 and January 2012, by gamekeepers 93 
authorized by the Swiss Cormorant Action Plan, in collaboration with the Swiss Agency for 94 
the Environment, Forests and Landscape and the Institute for Veterinary Bacteriology, 95 
Vetsuisse Faculty, Zurich, Switzerland. Twelve pooled cloacal samples were obtained from a 96 
total of 30 dissected cormorants.  97 
Each sample was incubated for 24 hours at 37 °C in 10 ml of EE Broth (BD, Franklin 98 
Lakes, USA) for enrichment. One loopful each of the enrichment cultures was inoculated onto 99 
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chromogenic Brilliance ESBL agar and Brilliance CRE agar (Oxoid, Hampshire, UK) to 100 
select for extended-spectrum ß-lactamase and carbapenemase producers, respectively, and 101 
incubated at 37 °C for 24 hours under aerobic conditions. All colonies with different 102 
coloration and morphology were picked from the selective plates and subcultured on sheep 103 
blood agar (Difco laboratories; 5% sheep blood, SB055, Oxoid) at 37 °C for 24 hours. 104 
Oxidase-negative isolates were thereafter subjected to identification by API ID 32 E 105 
(bioMérieux, Marcy l’Etoile, France).  106 
 107 
2.2 Antibiotic susceptibility testing and phenotypic ESBL detection 108 
 Susceptibility testing was performed by agar diffusion methods, using antibiotic disks 109 
(Becton Dickinson and Company, Maryland, USA) and Etest ESBL epsilometer strips 110 
(bioMérieux, Marcy l’Etoile, France), according to the manufacturers' protocols. Results were 111 
interpreted according to the criteria of the Clinical and Laboratory Standards Institute (CLSI)  112 
(CLSI, 2008). Strains exhibiting resistance to 3 or more antibiotic classes were classified as 113 
multidrug resistant. 114 
 115 
2.3 Characterization of β-lactamases 116 
Bacterial strains confirmed for either production of ESBLs or expression of higher 117 
generation cephalosporin resistance were further analysed by screening for bla genes. DNA 118 
was extracted by a standard heat lysis protocol. Thereafter, specific primer sets (custom-119 
synthesized by Microsynth, Balgach, Switzerland) were used to amplify β-lactamase-120 
encoding genes belonging to blaTEM, blaSHV and blaCTX-M  (Geser et al., 2012) and blaCMY 121 
families (Briñas et al., 2003; Endimiani et al., 2012), the latter supplemented with the 122 
following newly designed primer cmy-dn-3 from the blaCMY-2 downstream flanking region: 123 
5’ATGCGCATGGGATTTTCCTTGC3’. Resulting amplicons were purified using the PCR 124 
Purification Kit (QIAGEN, Courtaboeuf, France) according to the manufacturer’s 125 
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recommendations. Custom-sequencing was performed by Microsynth (Balgach, Switzerland) 126 
and the nucleotide and protein sequences were analysed with Codon Code Aligner V. 3.7.1.1. 127 
For database searches the BLASTN program of NCBI (http://www.ncbi.nlm.nih.gov/blast/) 128 
was used. 129 
 130 
2.4 Multi-locus sequence typing of ESBL-producers 131 
Internal fragments of 7 housekeeping genes (adk, fumC, gyrB, icd, mdh, purA, and 132 
recA) were sequenced  (Wirth et al., 2006) and alleles and sequence types (ST) were assigned 133 
in accordance with the E. coli MLST website (http://mlst.ucc.ie/). 134 
 135 
2.5 Determination of E. coli phylogenetic groups  136 
Phylogenetic analyses have shown that E. coli strains fall into four main groups (A, 137 
B1, B2, and D), in which groups A and B1 typically contain commensal isolates, and isolates 138 
of groups B2 and D are considered to be more likely to carry pathogenicity-associated genes  139 
(Clermont et al., 2000). After DNA extraction using a standard heat lysis protocol, ESBL-140 
producing E. coli isolates were subjected to phylogenetic grouping by PCR as described 141 
previously  (Clermont et al., 2000).  142 
 143 
2.6 Virulence factors in ESBL-producers 144 
Strains were examined for the presence of genes for putative virulence factors 145 
mediating adhesion (adhesion siderophore iha, long polar fimbriae lpfA, S fimbrial adhesin 146 
sfaS, and temperature sensitive haemagglutinin tsh), increasing iron-uptake (e.g. siderophore 147 
for iron iroN), and of genes encoding toxins (secreted autotransporter toxin sat, serine 148 
protease pic, vacuolating toxin vat, and cytotoxic necrotizing factor cnf1). An ArrayTube-149 
based DNA microarray approach (Clondiag Chip Technologies, Jena, Germany) was used 150 
according to the manufacturer’s instructions. 151 
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3. Results and discussion 153 
Using selective isolation on Brilliance ESBL agar plates, phenotypically positive 154 
ESBL-producing Escherichia coli were detected from 2 pigeon samples (W117E and W132) 155 
and 2 great cormorant samples (W34 and W43). Selective cultivation on Brilliance CRE agar 156 
plates gave rise to 2 isolates originating from pigeons (W117C and W265). One pigeon 157 
(W117) was thus found to have harboured 2 distinct strains; one selected from an ESBL- the 158 
other from a CRE- agar plate (W117E and W117C, respectively). In total, 6 resistant strains 159 
were collected for analysis.  160 
The antibiotic susceptibility profiles of the E. coli isolates are summarized in Table 1. 161 
On account of their resistance patterns, all the isolates were classified multidrug resistant. All 162 
strains were resistant to ampicillin and the 1st-generation cephalosporin cephalothin. Three of 163 
6 isolates (W117E, a pigeon- and W34 and W43, cormorant isolates, respectively) tested 164 
resistant to third-generation cephalosporin cefotaxime in the disk diffusion test and 165 
susceptible to ampicillin-clavulanic acid, thus suggesting an ESBL phenotype. Further 3 166 
strains, W117C, W132 and W265 (all from pigeons), tested resistant to ampicillin-clavulanic 167 
acid in the disk diffusion test and showed reduced susceptibility to cephalosporin-clavulanic 168 
acid combinations in the E tests, suggesting an AmpC-phenotype. All isolates remained 169 
susceptible to the 4th generation cephalosporin cefepime and to the carbapenem antibiotic 170 
imipenem. The latter result indicated the absence of carbapenemases in both the pigeon 171 
population as well as in the cormorants, despite initial growth on Brilliance CRE agar of 172 
strains W117C and W265, suggesting reduced susceptibility of these strains to the selective 173 
agent in the CRE medium.  174 
In addition, resistance to nalidixic acid was detected in 3 of 4 (75%) of the pigeon 175 
strains and in one cormorant strain (W43), the latter additionally testing resistant to 176 
ciprofloxacin. Resistance to aminoglycosides was restricted to streptomycin and identified in 177 
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2 pigeon and both cormorant strains.All isolates were resistant to tetracycline. One pigeon 178 
isolate (W117E) and both cormorant strains were resistant to sulfamethoxazole and 179 
trimethoprim. All strains tested fully susceptible to chloramphenicol. 180 
 181 
The results of ESBL-and AmpC gene identification, MLST analysis, determination of 182 
phylogenetic groups, and detection of putative virulence genes are summarized in Table 2. 183 
Thereby, three (W117C, W132 and W265) of the 4 strains (75%) originating from pigeons 184 
carried a blaCMY-2 gene, whereas one strain (W117E) harboured a blaCTX-M-15 gene. The 2 185 
strains (W34 and W43) isolated from cormorants carried blaCTX-M-15 and blaCTX-M-27, 186 
respectively. 187 
MLST typing identified all CMY-2-producers as belonging to genotype ST 457. The 188 
CTX-M-15 -producing strain isolated from a pigeon swab (W177E) exhibited a yet undefined 189 
MLST profile, due to a point mutation A to G in the gene mdh88 at nucleotide 69 (numbering 190 
according to www.mlst.ucc.ie). Strains isolated from cormorants were characterized as 191 
belonging to ST 120 in the case of the CTX-M-15-producer, and to ST 131 in the case of the 192 
strain expressing CTX-M-27, categorizing the latter as a member of the world-wide pandemic 193 
multiresistant clone strongly associated with potentially severe infections in humans and 194 
animals  (Rogers et al., 2011).  195 
Phylogenetic grouping showed that all CMY-2-producers belonged to pathogenicity-196 
associated extra-intestinal E. coli group D. The CTM-X-15-producing strain from a pigeon 197 
(W117E) was classified as belonging to group B2, defining it also as a potentially virulent 198 
extra-intestinal type, with heterogeneous distribution of virulence factors, as demonstrated by 199 
analysis of their virulence genes. Of the cormorant-originating strains, the CTM-X-15-positve 200 
isolate (W34) belonged to the commensal phylogenetic group B1, whereas the CTX-M-27-201 
producing strain was assigned to group B2, a phylogenetic group in which CTX-M ESBLs are 202 
found rarely, except in conjunction with clonal group ST 131  (Brisse et al., 2012).  203 
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Our study is the first investigation of the occurrence of ß-lactam-resistant E. coli in 204 
urban pigeons and wild cormorants in Switzerland. The data presented show that 1% of the 205 
sampled pigeon population hosts multidrug resistant, virulent extra-intestinal E. coli that 206 
produce either CTX-M-15 or the plasmid-encoded AmpC-ß-lactamase CMY-2. Furthermore, 207 
our results indicate that a proportion of these avian hosts carry more than one distinct strain of 208 
multidrug-resistant ß-lactamase-producing E. coli, thus increasing the risk of horizontal 209 
transmission of mobile antibiotic resistance genes among the host's faecal flora. This is 210 
particularly alarming, because urban pigeons live in close contact to humans and animals and 211 
are known to contribute, via faeces, to the spread of pathogens, including antibiotic-resistant 212 
bacteria  (Silva et al., 2009). While pigeons are known to host multidrug resistant E. coli, and 213 
CTX-M-15-producing E. coli have been detected in pigeons in isolated cases  (Guenther et 214 
al., 2010), a study performed recently by Radimerski and collaborators  (Radimersky et al., 215 
2010) declares, in contrast to our findings, the absence of ESBL-producing E. coli in a 216 
population of urban pigeons analysed in the city of Brno, Czech Republic. This illustrates the 217 
complexity of the epidemiology of ESBL-E. coli in the environment and suggests a 218 
geographical and temporal heterogeneity which needs to be monitored carefully. In this 219 
context, it is of particular interest that both feral pigeons and wild cormorants in Switzerland 220 
carry producers of CTX-M-15 - the ESBL type found most frequently (41%) among human 221 
carriers of ESBL producers in this country (Geser et al., 2012). 222 
As a further example of complex ß-lactam resistance distribution in urban birds, we 223 
report an OXA-1-producing E. coli isolated from a crow (Corvus corone ssp. corone), located 224 
in the city of Zurich (data not shown).  225 
The detection of CTX-M ESBLs in cormorants, especially of CTX-M-27 in the 226 
potentially highly virulent and pandemic E. coli clone ST 131 is worrisome. Together with the 227 
very recent first report of a CTX-M-27-positive isolate in cormorants by Tausova and 228 
collaborators  (Tausova et al., 2012), we provide evidence for the emergence of CTX-M-27-229 
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producing, multidrug-resistant epidemiologically important E. coli ST131 in water birds in 230 
Europe. A further indication that clonal group ST 131 producing CTM-X-27 is emerging 231 
continuously is its recent detection in companion animals in Japan  (Harada et al., 2012). 232 
Our study provides further evidence that synanthropic as well as water-associated 233 
birds should be considered environmental reservoirs of ESBL-producing E. coli, constituting 234 
a potential threat to human and animal health.  Further studies are necessary to gain insight to 235 
the factors that contribute to the dissemination of antibiotic resistant bacteria to and from 236 
wildlife. There is urgent need for surveillance of the prevalence of ESBL- and pAmpC-237 
producing E. coli in humans, animals and the environment. 238 
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